| Identification | Back Directory | [Name]
N-[2R-hydroxy-1S-(hydroxymethyl)-3E-heptadecen-1-yl-d7]-hexadecanamide | [CAS]
1840942-13-3 | [Synonyms]
C16 Ceramide-?d7
N-[2R-hydroxy-1S-(hydroxymethyl)-3E-heptadecen-1-yl-d7]-hexadecanamide | [Molecular Formula]
C34H67NO3 | [MOL File]
1840942-13-3.mol | [Molecular Weight]
537.91 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 0.15 mg/ml | [form ]
powder | [color ]
White to off-white | [InChIKey]
YDNKGFDKKRUKPY-HJSOYJPBSA-N | [SMILES]
OC[C@]([H])(NC(CCCCCCCCCCCCCCC)=O)[C@@](O)([H])/C=C/CCCCCCCCCCC(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H] |
| Hazard Information | Back Directory | [Uses]
C16 Ceramide-?d7 is used as an internal standard in the spectrometric diagnosis of cardiovascular diseases and complications. | [Biological Activity]
C16 Ceramide plays a vital role in apoptotic signaling. Examining the levels of the ceramides (Cer) d18:1/16:0Cer d18:1/18:0Cer d18:1/24:0and Cer d18:1/24:1 and ratios in human plasma facilitates the prognosis of fatal outcome of coronary artery disease. A newly described and validated liquid chromatography-tandem mass spectrometry methodology uses C16 Ceramide (d18:1/16:0) in a stable isotope form for their clinical-scaled measurement. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
TargetMol
|
| Tel: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|